文献
J-GLOBAL ID:201702276521974113
整理番号:17A0868027
タイプ2糖尿病の治療のための強力で選択的かつ経口的に利用できるソマトスタチン受容体サブタイプ5(SSTR5)アンタゴニストとしての新規5-オキサ-2,6-ジアザスピロ[3.4]oct-6-エン誘導体の発見【Powered by NICT】
Discovery of novel 5-oxa-2,6-diazaspiro[3.4]oct-6-ene derivatives as potent, selective, and orally available somatostatin receptor subtype 5 (SSTR5) antagonists for treatment of type 2 diabetes mellitus
著者 (14件):
Hirose Hideki
(Research Division Medicinal Chemistry Laboratory, SCOHIA PHARMA, Inc., 26-1, Muraoka-Higashi 2-Chome, Fujisawa, Kanagawa 251-8555, Japan)
,
Yamasaki Takeshi
(Research Division, Takeda Pharmaceutical Co., Ltd., Shonan Research Center, 26-1, Muraoka-Higashi 2-Chome, Fujisawa, Kanagawa 251-8555, Japan)
,
Ogino Masaki
(Research Division Medicinal Chemistry Laboratory, SCOHIA PHARMA, Inc., 26-1, Muraoka-Higashi 2-Chome, Fujisawa, Kanagawa 251-8555, Japan)
,
Mizojiri Ryo
(Research Division, Takeda Pharmaceutical Co., Ltd., Shonan Research Center, 26-1, Muraoka-Higashi 2-Chome, Fujisawa, Kanagawa 251-8555, Japan)
,
Tamura-Okano Yumiko
(Research Division, Takeda Pharmaceutical Co., Ltd., Shonan Research Center, 26-1, Muraoka-Higashi 2-Chome, Fujisawa, Kanagawa 251-8555, Japan)
,
Yashiro Hiroaki
(Research Division, Takeda Pharmaceutical Co., Ltd., Shonan Research Center, 26-1, Muraoka-Higashi 2-Chome, Fujisawa, Kanagawa 251-8555, Japan)
,
Muraki Yo
(Research Division, Takeda Pharmaceutical Co., Ltd., Shonan Research Center, 26-1, Muraoka-Higashi 2-Chome, Fujisawa, Kanagawa 251-8555, Japan)
,
Nakano Yoshihide
(Global Procurement, Takeda Pharmaceutical Co., Ltd., 26-1, Muraoka-Higashi 2-Chome, Fujisawa, Kanagawa 251-8555, Japan)
,
Sugama Jun
(Research Division Medicinal Chemistry Laboratory, SCOHIA PHARMA, Inc., 26-1, Muraoka-Higashi 2-Chome, Fujisawa, Kanagawa 251-8555, Japan)
,
Hata Akito
(Research Division, Takeda Pharmaceutical Co., Ltd., Shonan Research Center, 26-1, Muraoka-Higashi 2-Chome, Fujisawa, Kanagawa 251-8555, Japan)
,
Iwasaki Shinji
(Research Division, Takeda Pharmaceutical Co., Ltd., Shonan Research Center, 26-1, Muraoka-Higashi 2-Chome, Fujisawa, Kanagawa 251-8555, Japan)
,
Watanabe Masanori
(Research Division Medicinal Chemistry Laboratory, SCOHIA PHARMA, Inc., 26-1, Muraoka-Higashi 2-Chome, Fujisawa, Kanagawa 251-8555, Japan)
,
Maekawa Tsuyoshi
(Research Division Medicinal Chemistry Laboratory, SCOHIA PHARMA, Inc., 26-1, Muraoka-Higashi 2-Chome, Fujisawa, Kanagawa 251-8555, Japan)
,
Kasai Shizuo
(Research Division Medicinal Chemistry Laboratory, SCOHIA PHARMA, Inc., 26-1, Muraoka-Higashi 2-Chome, Fujisawa, Kanagawa 251-8555, Japan)
資料名:
Bioorganic & Medicinal Chemistry
(Bioorganic & Medicinal Chemistry)
巻:
25
号:
15
ページ:
4175-4193
発行年:
2017年08月01日
JST資料番号:
W0556A
ISSN:
0968-0896
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)